Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Severe hypophosphataemia following oral bisphosphonate treatment in a patient with osteoporosis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Severe acute hepatitis E infection presenting with acute abdomen and meningoencephalitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intracranial entrapment of a haemodialysis catheter guidewire

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hepatic epitheloid haemangioendothelioma: a rare malignant tumour

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long-term Consequences of Undiagnosed Celiac Seropositivity

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Alexithymia and Inflammatory Bowel Disease: A Systematic Review

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

A 76-year-old woman was treated with oral bisphosphonate, alendronate, for osteoporosis in an outpatient clinic. Routine blood tests 4 months after alendronate prescription surprisingly revealed severe hypophosphataemia. The patient was hospitalised and treated with intravenous and oral phosphate supplements. Alendronate was later reintroduced as treatment for osteoporosis and the patient once again presented with severe hypophosphataemia in subsequent routine blood tests. The patient had only presented with lower extremity pain, muscle weakness and difficulty walking. Blood tests in the emergency department both times reconfirmed severe hypophosphataemia. Plasma (p-)ionised calcium levels were normal or slightly elevated and p-parathyroid hormone levels were normal or slightly suppressed. The p-25-hydroxyvitamin-D and p-creatine were in the normal range. Critical illness, malabsorption, nutritional issues and genetics were reviewed as potential causes but considered unlikely. Phosphate levels were quickly restored each time on replacement therapy and the case was interpreted as bisphosphonate-induced severe hypophosphataemia.

Original languageEnglish
JournalBMJ Case Reports
Volume13
Issue number10
ISSN1757-790X
DOIs
Publication statusPublished - 8 Oct 2020

ID: 61114747